Double-hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report

被引:1
|
作者
Zhang, Yan [1 ]
Wang, Wei [1 ]
Chen, Tingting [1 ,2 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Dept Pathol,Key Lab Birth Defects & Related Dis Wo, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Dept Pathol,Key Lab Birth Defects & Related Dis Wo, 20 Renmin Rd South, Chengdu 610041, Sichuan, Peoples R China
关键词
lymphoma; MYC; BCL2; dual-hit lymphoma; bilateral ovary;
D O I
10.3892/ol.2023.13727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lymphoid neoplasm with 18q21.3/BCL2 and 8q24/MYC translocation to immunoglobulin genes as dual-hit lymphoma in female bilateral ovaries is rare and has a poor clinical outcome. The present study reported on the case of a 33-year-old female, who was admitted to the hospital due to lower abdominal distension aggravated during defecation but with no obvious inducement. The B-ultrasound revealed bilateral adnexal solid masses and the pathological examination indicated advanced B-cell lymphoma (HGBL) with MYC and BCL2 gene rearrangement. The patient then received R-CHOP treatment, but the effects were poor. Rare extranodal HGBL presentations with MYC and BCL2 rearrangement should be considered in the differential diagnosis of masses at unusual sites, such as the adnexa. Due to their aggressive nature, early and prompt recognition of these lymphomas is essential for appropriately administering therapies.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Targeting MYC and BCL2 by a natural compound for "double-hit" lymphoma
    Liu, Xiaoqian
    Xu, Senlin
    Zhang, Jiawei
    Fan, Mingjie
    Xie, Jun
    Zhang, Bingfeng
    Li, Hongzhi
    Yu, Guohua
    Liu, Yinghui
    Zhang, Yuanfeng
    Song, Joo
    Horne, David
    Chan, Wing C.
    Chu, Xiaoxia
    Huang, Wendong
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (03) : 356 - 369
  • [2] Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma
    Yoshida, Maki
    Ichikawa, Ayako
    Miyoshi, Hiroaki
    Kiyasu, Junichi
    Kimura, Yoshizo
    Niino, Daisuke
    Ohshima, Koichi
    PATHOLOGY INTERNATIONAL, 2015, 65 (09) : 486 - 489
  • [3] MYC translocation partner determines survival in double-hit BCL2/MYC lymphoma
    Pedersen, M. O.
    Gang, A. O.
    Poulsen, T. S.
    Knudsen, H.
    Lauritzen, A. F.
    Gang, U. O.
    Nielsen, S. L.
    Norgaard, P. H.
    APMIS, 2012, 120 : 6 - 7
  • [4] Double-hit lymphoma (rearrangements of MYC, BCL-2) during pregnancy: A case report
    Xie, Fan
    Zhang, Li-Hui
    Yue, Ya-Qing
    Gu, Lu-Lu
    Wu, Fei
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (02) : 482 - 488
  • [5] Double-hit lymphoma(rearrangements of MYC, BCL-2) during pregnancy: A case report
    Fan Xie
    Li-Hui Zhang
    Ya-Qing Yue
    Lu-Lu Gu
    Fei Wu
    World Journal of Clinical Cases, 2021, 9 (02) : 482 - 488
  • [6] MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma
    Li, Shaoying
    Lin, Pei
    Young, Ken H.
    Kanagal-Shamanna, Rashmi
    Yin, C. Cameron
    Medeiros, L. Jeffrey
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (05) : 315 - 326
  • [8] Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?
    Katsushima, Hiroki
    Fukuhara, Noriko
    Konosu-Fukaya, Sachiko
    Himuro, Masahito
    Kitawaki, Yuko
    Ichikawa, Satoshi
    Ishizawa, Kenichi
    Sasano, Hironobu
    Harigae, Hideo
    Ichinohasama, Ryo
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 758 - 762
  • [9] MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate Treatment
    Kurimoto, Ryota
    Shono, Katsuhiro
    Onoda, Masahiro
    Yamamoto, Kyohei
    Yokota, Akira
    INTERNAL MEDICINE, 2016, 55 (16) : 2271 - 2275
  • [10] Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
    Weiping Li
    Shiv K. Gupta
    Weiguo Han
    Ryan A. Kundson
    Sara Nelson
    Darlene Knutson
    Patricia T. Greipp
    Sherine F. Elsawa
    Eduardo M. Sotomayor
    Mamta Gupta
    Journal of Hematology & Oncology, 12